Home » Roche to File T-DM1 Breast Cancer Drug on Good Data
Roche to File T-DM1 Breast Cancer Drug on Good Data
Roche said patients with an aggressive type of breast cancer lived longer after taking its experimental “armed antibody” drug without the disease worsening than those on a mix of GlaxoSmithKline drug Tykerb and Roche’s Xeloda.
The Baltimore Sun
The Baltimore Sun
Upcoming Events
-
07May
-
14May
-
30May